Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cajanin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105030750B details novel cajanin analogues with anti-HCV and anti-HIV activity, offering scalable synthesis routes for pharmaceutical intermediate manufacturing.